Endexx Enters Into Definitive Agreement to Acquire GreenLeaf Consulting LLC.
July 02 2014 - 8:50AM
Marketwired
Endexx Enters Into Definitive Agreement to Acquire GreenLeaf
Consulting LLC.
GreenLeaf Brings Revenue and Expertise to Endexx
CAVE CREEK, AZ--(Marketwired - Jul 2, 2014) - Endexx
Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of
innovative medical marijuana management and technology solutions,
announced today that it has entered into a definitive agreement to
acquire the operations and services of GreenLeaf Consulting LLC., a
pioneering New Jersey consulting firm for the medical
marijuana industry.
GreenLeaf Consulting provides
consulting and advisory services to the cannabis industry
participants in several states to assist with application
preparation, securing licensing and compliance protocol. Mr.
Todd Davis, CEO Endexx, stated: "Mr. Stevens bring Endexx a high
level of expertise in both compliance matters and political
navigation in the legal Medical Cannabis industry. His background
and success provide a powerful and immediate presence in the
Midwest and East coast states. The Endexx management team continues
to strengthen and we are very excited to work with our new partner,
Joe Stevens."
Mr. Joseph Stevens, Founder
and President of Greenleaf Consulting and Greenleaf Compassion
Center of New Jersey, stated: "I am excited to collaborate with the
Endexx team. My proven experience guiding medical marijuana
companies through complex regulatory requirements, coupled with
Endexx's outstanding technology solutions, creates a one-stop shop
for seed to sale compliance solutions for the cannabis
industry. I anticipate that our strategic alliance will
provide Endexx and Greenleaf Consulting with new opportunities and
synergies that will allow us to continue to significantly grow in
our market."
About:
Joseph Stevens is an East
Coast pioneer in the medical marijuana industry. Joseph single
handedly navigated through NJ's highly restrictive Compassionate
Use of Medicinal Marijuana Act and Regulations, opening Greenleaf
Compassion Center in December 2012, the first operational facility
in the state. He worked hand in hand with the NJ Department of
Health and Senior Services to meet the stringent State compliance
requirements including, but not limited to security, inventory
management, risk assessment, personnel management, cultivation
procedures, and safe patient access. He assisted the
Department of Health in establishing laboratory testing including
the development of protocol for isolating and identifying
quantities of THC, THC-A and CBD's. The results of his success
with compliance set the standard for the remaining licensees to
meet in order to be approved for becoming operational.
Joseph created Greenleaf
Consulting, LLC and consulted for Curaleaf in Simsbury CT to assist
with their marijuana production facility application. Curaleaf
was one of four producer applicants awarded permitting in January
2014. He has also provided consulting services in
Massachusetts for Be Well Organics and MassMedi-Spa. He has
most recently been engaged to assist an Illinois group with
licensing and is in discussions with others in Arizona, New
Hampshire, and Illinois who are all in pursuit of licensing.
Joseph has donated countless
hours to working with parents of children with autism and seizure
disorders who are interested in CBD treatment. He has also
consulted with many public office officials as well as regulatory
personnel in New York, Delaware, and Oregon to provide insight into
the application processes, development of rules and regulations,
and compliance matters as they relate to the introduction of state
marijuana programs.
Under the terms of the
definitive agreement, Endexx and GreenLeaf establish a long term
relationship to capitalize on growth opportunities arising from the
adoption of states' medical marijuana programs. The relationship
allows the integration of Greenleaf into the M3hub compliance
platform and supports the implementation of standardized solutions
for the industry, enhancing the overall value of the offering.
About Endexx:
Endexx provides innovative
medical marijuana management and technology solutions. The Company
has two products that launched in the first half of 2014 -- the
m3hub and the Autospense™. Both products provide essential
solutions to promote regulatory compliance and full accountability
through "seed to sale" inventory management and tracking. Based on
principles developed by the pharmacological industry, the m3hub
database is the first standardized software platform for tracking
pharmaceutical grade marijuana to support a Centralized Medical
Marijuana Industry Repository and maintain compliance with the laws
of the federal government and state and local regulatory bodies.
The Autospense™ is a high-tech marijuana inventory control and
dispensing machine, which provides up to the minute accounting
details and protects the security of the product as well as the
patient. By automating the dispensing process, Autospense™
increases productivity and reduces costs for marijuana retailers,
while enhancing their service quality by reducing transaction time
for customers. www.endexx.com, www.m3hub.com,
www.autospense.com
Safe Harbor Notice This press
release may contain "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995, such as
statements relating to financial results and plans for future
development activities, and are thus prospective. Forward-looking
statements include all statements that are not statements of
historical fact regarding intent, belief or current expectations of
the Company, its directors or its officers. Investors are cautioned
that any such forward-looking statements are not guarantees of
future performance and involve risks and uncertainties, many of
which are beyond the Company's ability to control. Actual results
may differ materially from those projected in the forward-looking
statements. Among the factors that could cause actual results to
differ materially from those indicated in the forward-looking
statements are risks and uncertainties associated with the
Company's business and finances in general, including the ability
to continue and manage its growth, competition, global economic
conditions and other factors discussed in detail in the Company's
periodic filings with the Security and Exchange Commission. The
Company undertakes no obligation to update any forward-looking
statements.
CONTACT: For further investor and media information Endexx
Corporation Todd Davis Chairman & CEO endexx@endexx.com
480-595-6900 IRTH Communications Robert Haag Managing Director
edxc@irthcommunications.com 866-976-4784
Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Jan 2024 to Jan 2025
